simplywall.st Earnings
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 384
- Sources here
- 17
- Companies here
- 13
Active search
384 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
SWS Partners Acquires Shares of 2,336 MercadoLibre, Inc. $MELI
SWS Partners has acquired 2,336 shares of MercadoLibre, Inc. (NASDAQ:MELI) for approximately $3.965 million, making it their 29th largest holding. Other institutional investors like Bison Wealth LLC and Empowered Funds LLC also adjusted their stakes in the company. MercadoLibre has a "Moderate Buy" consensus …
Oppenheimer Asset Management Inc. Acquires Shares of 7,299 MercadoLibre, Inc. $MELI
Oppenheimer Asset Management Inc. has acquired a new stake of 7,299 shares in MercadoLibre, Inc. (NASDAQ:MELI), valued at approximately $12.39 million during the second quarter. Other institutional investors have also adjusted their holdings in the e-commerce and fintech company, and a director recently increased …
Kolibri Global Energy (NASDAQ:KGEI) Rating Increased to Buy at Wall Street Zen
Wall Street Zen has upgraded Kolibri Global Energy (NASDAQ:KGEI) from a "hold" to a "buy" rating, though other analysts like Weiss Ratings maintain a "hold" position. The company's shares opened up 3.0% at $5.77, reflecting a market capitalization of $206 million. Kolibri Global Energy …
Inhibrx Biosciences (INBX) holders disclose 1.49M-share, 9.99% position
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 1,489,443 shares of Inhibrx Biosciences, Inc. (INBX) common stock, representing 9.99% of the class. This stake includes common shares and pre-funded warrants, with the exercise of …
Schonfeld Strategic Advisors (INBX) discloses 5.33% Inhibrx Biosciences stake in 13G filing
Schonfeld Strategic Advisors LLC has disclosed a 5.33% beneficial ownership stake in Inhibrx Biosciences, Inc. (INBX) through a Schedule 13G filing. This amounts to 781,678 shares of common stock, representing 5.33% of the 14,671,186 shares outstanding as of May 8, 2026. Schonfeld maintains sole …
Kolibri Global Energy Inc. Announces Another Record for Its Highest Quarterly Revenue of $22.5 Million With a 46% Production Increase and a 197% Net Income Increase for the Second Quarter of 2026
Kolibri Global Energy Inc. reported a record quarterly revenue of $22.5 million for Q2 2026, marking a 109% increase from the previous year. This surge was driven by a 46% rise in production, reaching 4,690 BOEPD, and a 41% increase in average prices. The …
Airbnb vs. MercadoLibre: Evaluating Revenue Trajectories Between These Consumer Companies
Airbnb: Ongoing Seasonal Fluctuations in Its Quarterly Revenue Airbnb (NASDAQ:ABNB) primarily manages a global digital marketplace that effectively connects independent hosts offering unique local accommodations with international travelers looking to book short-term vacation rentals or distinct private rooms. While introducing its new Summer Release …
Gibraltar Industries CEO, CFO to join Seaport Research Partners annual summer investor conference
Gibraltar Industries announced that its Chairman and CEO, Bill Bosway, and CFO, Joe Lovechio, will attend the Seaport Research Partners Annual Summer Investor Conference on August 18, 2026. During the event, they are scheduled to hold investor meetings. This news brief was generated by …
Gibraltar to Attend Seaport Research Partners 2026 Annual Summer Investor Conference
BUFFALO, N.Y., August 14, 2026--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential, agtech and infrastructure markets, today announced that Chairman and Chief Executive Officer Bill Bosway and Chief Financial Officer Joe Lovechio are scheduled …
Inhibrx Biosciences (NASDAQ:INBX) Shares Gap Down After Earnings Miss
Inhibrx Biosciences (NASDAQ:INBX) experienced a share price drop after missing earnings estimates, opening at $91.80, down from its previous close of $97.01. The company reported an EPS of $(2.34) against an estimated $(2.28). Analyst ratings for INBX are mixed, with an average "Hold" rating …
Kolibri Global Energy Inc. Stock Surges 5.67% as Trading Activity Spikes and Market Attention Builds
Kolibri Global Energy Inc. (TSX:KEI) experienced a 5.67% stock surge on August 13, 2026, driven by a spike in trading activity, though the exact catalyst remains unverified. The company is an oil and natural gas producer focused on its Tishomingo field in Oklahoma. Investors …
Inhibrx Biosciences, Inc. (NASDAQ:INBX) Given Consensus Recommendation of "Hold" by Brokerages
Inhibrx Biosciences (NASDAQ:INBX) has received a consensus "Hold" recommendation from brokerages, with an average 12-month price target of $150.00. The company recently reported a quarterly EPS of -$2.34, missing analyst estimates, and institutional investors now own 82.46% of the stock. BlackRock Inc. notably acquired …
Inhibrx Biosciences (NASDAQ:INBX) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS
Inhibrx Biosciences (NASDAQ:INBX) reported a quarterly loss of $2.34 per share, missing analysts' consensus estimates by $0.06. Following the announcement, the stock fell 1.4% to $97.01. Despite mixed analyst sentiment resulting in a "Hold" rating, institutional investors hold a significant 82.46% of the company's …
MercadoLibre (MELI) Stock Trades Up, Here Is Why
MercadoLibre (MELI) Stock Trades Up, Here Is Why What Happened? Shares of latin American e-commerce and fintech company MercadoLibre (NASDAQ:MELI) jumped 5% in the morning session after JP Morgan raised its price target on the stock to $2,150 from $1,900. While the firm maintained …
Sharemaestro market context Price above Trend Line 52 weeks -31.0%Form 8K Inhibrx Biosciences Inc For: 13 August By Investing.com
This article reports on the filing of a Form 8K by Inhibrx Biosciences Inc. for August 13. The brief notice highlights the company's regulatory submission without providing further details on its content. It includes the stock symbol INBX, which saw a slight decrease.
Inhibrx Biosciences (INBX) deepens losses but reports pivotal ozekibart and INBRX-106 data
Inhibrx Biosciences (INBX) reported a net loss of $70.1 million for the first half of 2026, with no revenue, while holding $133.3 million in cash and equivalents. Despite the losses, the company advanced its clinical pipeline, with ozekibart achieving a statistically significant progression-free survival …
FDA Sets April 2027 Goal Date for Inhibrx's Ozekibart
Inhibrx reported a net loss of $36.7 million in Q2 2026, with R&D expenses at $23.9 million and G&A at $8.3 million. The company secured an amended loan with Oxford Finance for up to $325.0 million, with $100.0 million already funded. The FDA accepted …
Kolibri Global Energy (NASDAQ:KGEI) Releases Earnings Results, Beats Estimates By $0.02 EPS
Kolibri Global Energy (NASDAQ:KGEI) announced strong second-quarter results, beating EPS estimates by $0.02 with a reported $0.23 EPS. The company achieved record revenue of $22.5 million and more than doubled its adjusted EBITDA to $16.4 million, driven by a 46% increase in production. Despite …
Earnings call transcript: Kolibri Global Energy posts record Q2 2026 revenue
Kolibri Global Energy reported record second-quarter 2026 revenue of $22.5 million, marking a 109% increase year-over-year, surpassing Wall Street estimates. Despite an EPS miss ($0.23 actual vs. $0.25 forecast), the company's stock rose 8.3% due to strong production, higher cash flow, and improved borrowing …
MercadoLibre (MELI) Faces A Valuation Test As Record Q2 Revenue Meets Margin Pressure
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. MercadoLibre (MELI) has drawn fresh attention after reporting Q2 2026 revenue above US$10b, while earnings per share and net income declined year on …
KGEI SEC Filings - Kolibri Global Energy Inc. 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Kolibri Global Energy Inc. (KGEI) SEC filings, including annual reports (10-K), quarterly reports (10-Q), material event reports (8-K), and insider trading forms (Form 4). It highlights recent Form 6-K filings detailing operational updates, financial results, and administrative …
Kolibri Global Energy Inc. (KGEI) Q2 Earnings and Revenues Beat Estimates
Kolibri Global Energy Inc. (KGEI) reported Q2 earnings of $0.23 per share, surpassing the Zacks Consensus Estimate of $0.21, and revenues of $22.54 million, exceeding the estimate by 8.07%. Despite outperforming market expectations in Q2 and showing a 37.9% share increase year-to-date, the stock …
Sharemaestro market context Trend signal active 52 weeks +4.9%Kolibri Global Energy Q2 Results: Net income up 197%, revenue surges 109%
Kolibri Global Energy Inc. reported a record Q2 2026 performance with net income surging 197% year-on-year to $8.5 million and revenue, net of royalties, more than doubling to $22.5 million. This growth was driven by a 46% increase in average production to 4,690 BOEPD …